We are live on
!
Find out more
AC
Athos Capital Portfolio holdings
AUM
$324M
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
+8.63%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$499M
AUM Growth
-$99.5M
(-17%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-26.33%
Top 10 Holdings %
Top 10 Hldgs %
40.92%
Holding
243
New
104
Increased
7
Reduced
5
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$23.5M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$14.9M |
| 3 |
Willis Towers Watson
WTW
|
+$11.8M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9.42M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$9.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$110M |
| 2 |
GOAC
GO Acquisition Corp. Class A Common Stock
GOAC
|
+$17.4M |
| 3 |
RP
RealPage, Inc.
RP
|
+$13.3M |
| 4 |
CLGX
Corelogic, Inc.
CLGX
|
+$11.8M |
| 5 |
STAY
Extended Stay America, Inc. Paired Share Unit
STAY
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.3% |
| 2 | Technology | 16.74% |
| 3 | Healthcare | 11.05% |
| 4 | Industrials | 10.4% |
| 5 | Communication Services | 8.46% |
Similar funds
THCM
WG
FAL
AIA
DMC
KL
UOC
MFA
Athos Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Athos Capital held 243 positions worth $499M, down 17% from $599M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Athos Capital withdrew a net $132M in Q2 2021, closing 82 positions and reducing 5 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $110M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Athos Capital opened a new position in Xilinx Inc worth $26.7M.
- Athos Capital's largest Q2 2021 buy was Xilinx Inc: 184,800 shares worth $26.7M.
- Athos Capital added most to Kansas City Southern in Q2 2021, an estimated $14.9M increase.
- Athos Capital's biggest Q2 2021 reduction was DouYu International Holdings, cutting an estimated $10.5M.
- Athos Capital fully exited China Biologic Products Holdings, Inc. in Q2 2021, selling an estimated $110M.
- Athos Capital's ten largest holdings make up 41% of its $499M portfolio in Q2 2021.
- Athos Capital opened 104 new positions and closed 82 in Q2 2021.
- Athos Capital's portfolio value fell 17% quarter-over-quarter to $499M.
Based on Athos Capital's 13F filing for Q2 2021, filed 12 Aug 2021.